Friday, January 8, 2021

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in February-March

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its COVID-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year.

from IndiaTV India: Google News Feed https://ift.tt/2XozHrk
via
at
Labels:

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Subscribe to: Post Comments (Atom)

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...